U.S. Food and Drug Administration
rule

FDA Consumer Magazine

Volume 40, Number 2 | March-April 2006

cover art shows two feet

Departments

Observations
A message from the editor of FDA Consumer.

Updates
The latest information on FDA-related issues, gathered from FDA news releases and other sources.

FDA Consumer Quiz
Test your knowledge about the topics in this issue.

The Last Word
Commentary: Treating Migraine: Be Proactive

Features

Cover Story
Taking Care of Your Feet

A guide to preventing and treating some common foot problems.

Safety Alert on Blood Glucose Meters
The FDA warns that some devices inadvertently switch from the U.S. standard of measurement to the international standard,
sometimes causing misinterpretation of readings.

Fraudulent, Unapproved Influenza-Related Products
The FDA cracks down on phony flu products.

The FDA Speeds Medical Treatments for Serious Diseases
Products intended to treat serious or life-threatening illnesses make it to the market more quickly if they qualify for one of three distinct programs.

Proper Use of Fentanyl Pain Patches
The FDA encourages safe use of a skin patch that delivers a strong opiate into the bloodstream.

The FDA Announces New Prescription Drug Information Format
Major changes to package inserts will make drug information more accessible.

First Inhaled Insulin Product Approved
The nation’s 5 million people who inject insulin to control their diabetes now have an alternative.

Managing Migraines
More treatment options include drugs to prevent a migraine attack as well as options to stop migraine pain.

Food Labels Identify Allergens More Clearly
New law helps to demystify lists of allergy-triggering ingredients on food labels.

FDA Consumer is the official magazine of the U.S. Food and Drug Administration.

Text in the articles in FDA Consumer may be republished without permission. Credit to FDA Consumer as the source is appreciated.


rule